196 related articles for article (PubMed ID: 20581892)
1. Juvenile thyrotoxicosis--a South Island, New Zealand experience with long-term outcome.
Brownlie BE; Hunt PJ; Turner JG
N Z Med J; 2010 Apr; 123(1313):23-31. PubMed ID: 20581892
[TBL] [Abstract][Full Text] [Related]
2. Thyrotoxicosis in children: treatment and outcome.
Jaruratanasirikul S; Leethanaporn K; Sriplung H
J Med Assoc Thai; 2006 Jul; 89(7):967-73. PubMed ID: 16881428
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease in children and adolescents: response to long-term treatment.
Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.
Kourime M; McGowan S; Al Towati M; Ahmed SF; Stewart G; Williamson S; Hunter I; Donaldson MDC
Arch Dis Child; 2018 Jul; 103(7):637-642. PubMed ID: 29269558
[TBL] [Abstract][Full Text] [Related]
7. Etiology and outcome of thyrotoxicosis at a university hospital.
Akbar DH; Mushtaq MM; Al-Sheik AA
Saudi Med J; 2000 Apr; 21(4):352-4. PubMed ID: 11533817
[TBL] [Abstract][Full Text] [Related]
8. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
9. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
Modebe O
Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
[TBL] [Abstract][Full Text] [Related]
10. The management of Graves' disease in New Zealand: results of a national survey.
Ford HC; Delahunt JW; Feek CM
N Z Med J; 1991 Jun; 104(914):251-2. PubMed ID: 2057150
[TBL] [Abstract][Full Text] [Related]
11. Juvenile hyperthyroidism: an experience.
Bhadada S; Bhansali A; Velayutham P; Masoodi SR
Indian Pediatr; 2006 Apr; 43(4):301-7. PubMed ID: 16651668
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of Graves disease in childhood and adolescence: an institutional experience.
Sherman J; Thompson GB; Lteif A; Schwenk WF; van Heerden J; Farley DR; Kumar S; Zimmerman D; Churchward M; Grant CS
Surgery; 2006 Dec; 140(6):1056-61; discussion 1061-2. PubMed ID: 17188157
[TBL] [Abstract][Full Text] [Related]
13. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and Management of Children with Thyrotoxicosis.
Leung AKC; Leung AAC
Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
[TBL] [Abstract][Full Text] [Related]
16. Prediction of outcome in Graves' disease after carbimazole treatment.
Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
18. Experience with carbimazole in the drug treatment of the hyperthyroidism of Graves' diseases in Nigerians.
Modebe O
East Afr Med J; 1992 Mar; 69(3):153-6. PubMed ID: 1505405
[TBL] [Abstract][Full Text] [Related]
19. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
[TBL] [Abstract][Full Text] [Related]
20. Prediction of remission after antithyroid drug treatment in Graves' disease.
Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
